%20INC./other/GINWA_ENTERPRISE_GROUP_INC.-logo.png)
GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings
Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 金花企业(集团)股份有限公司关于涉及中小投资者诉讼的进展公告 | 2025-01-17 | Chinese | |
| 金花企业(集团)股份有限公司2024年第二次临时股东大会决议公告 | 2024-12-31 | Chinese | |
| 陕西博硕律师事务所关于金花企业(集团)股份有限公司2024年第二次临时股东大会的法律意见书 | 2024-12-31 | Chinese | |
| 金花企业(集团)股份有限公司关于签订股权转让协议之补充协议(二)暨关联交易的进展公告 | 2024-12-31 | Chinese | |
| 金花企业(集团)股份有限公司关于会计差错更正的公告 | 2024-12-25 | Chinese | |
| 金花企业(集团)股份有限公司2023年年度报告(更正版) | 2024-12-25 | Chinese |
Browse filings by year
26 years- 2026 57 filings
- 2025 109 filings
- 2024 101 filings
- 2023 125 filings
- 2022 133 filings
- 2021 103 filings
- 2020 144 filings
- 2019 67 filings
- 2018 80 filings
- 2017 105 filings
- 2016 103 filings
- 2015 54 filings
- 2014 47 filings
- 2013 28 filings
- 2012 35 filings
- 2011 44 filings
- 2010 30 filings
- 2009 42 filings
- 2008 62 filings
- 2007 75 filings
- 2006 62 filings
- 2005 37 filings
- 2004 21 filings
- 2003 16 filings
- 2002 29 filings
- 2001 6 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
1 filing
| |||||
| 40284515 | 金花企业(集团)股份有限公司关于涉及中小投资者诉讼的进展公告 | 2025-01-17 | Chinese | ||
|
2024
14 filings
| |||||
| 40284509 | 金花企业(集团)股份有限公司2024年第二次临时股东大会决议公告 | 2024-12-31 | Chinese | ||
| 40284497 | 陕西博硕律师事务所关于金花企业(集团)股份有限公司2024年第二次临时股东大会的法律意见书 | 2024-12-31 | Chinese | ||
| 40284489 | 金花企业(集团)股份有限公司关于签订股权转让协议之补充协议(二)暨关联交易的进展公告 | 2024-12-31 | Chinese | ||
| 40284481 | 金花企业(集团)股份有限公司关于会计差错更正的公告 | 2024-12-25 | Chinese | ||
| 40284466 | 金花企业(集团)股份有限公司2023年年度报告(更正版) | 2024-12-25 | Chinese | ||
| 40284417 | 金花企业(集团)股份有限公司第十届董事会第十五次会议决议公告 | 2024-12-25 | Chinese | ||
| 40284410 | 金花企业(集团)股份有限公司2023年半年度报告摘要(更正版) | 2024-12-25 | Chinese | ||
| 40284396 | 金花企业(集团)股份有限公司关于部分募集资金投资项目延期的公告 | 2024-12-25 | Chinese | ||
| 40284391 | 金花企业(集团)股份有限公司2023年半年度报告(更正版) | 2024-12-25 | Chinese | ||
| 40284346 | 金花企业(集团)股份有限公司2023年第三季度报告(更正版) | 2024-12-25 | Chinese | ||
| 40284339 | 金花企业(集团)股份有限公司2023年年度报告摘要(更正版) | 2024-12-25 | Chinese | ||
| 40284306 | 金花企业(集团)股份有限公司第十届监事会第十次会议决议公告 | 2024-12-25 | Chinese | ||
| 40284296 | 国金证券股份有限公司关于金花企业(集团)股份有限公司部分募投项目延期的核查意见 | 2024-12-25 | Chinese | ||
| 40284283 | 金花企业(集团)股份有限公司关于公司董事长收到中国证券监督管理委员会立案告知书的公告 | 2024-12-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GINWA ENTERPRISE (GROUP) INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56468/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56468 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56468 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56468 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56468}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GINWA ENTERPRISE (GROUP) INC. (id: 56468)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.